AlphaCentric Advisors’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$934K Hold
2024
Q2
$976K Hold
2024
Q1
$1.7M Hold
2023
Q4
$973K Hold
2023
Q3
$1.51M Buy
2023
Q2
$1.45M Buy
2023
Q1
$934K Buy
2021
Q4
$900K Buy
2021
Q3
$792K Buy
2021
Q2
$841K Buy
2021
Q1
$547K Buy
2020
Q4
$263K Buy